These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 35301544)
1. Effect of videourodynamic subtypes on treatment outcomes of female dysfunctional voiding. Lee CL; Chen SF; Jiang YH; Kuo HC Int Urogynecol J; 2022 May; 33(5):1283-1291. PubMed ID: 35301544 [TBL] [Abstract][Full Text] [Related]
2. Therapeutic Effects of Urethral Sphincter Botulinum Toxin A Injection on Dysfunctional Voiding with Different Videourodynamic Characteristics in Non-Neurogenic Women. Jiang YH; Lee CL; Chen SF; Kuo HC Toxins (Basel); 2021 May; 13(5):. PubMed ID: 34069448 [TBL] [Abstract][Full Text] [Related]
3. Videourodynamic analysis of the urethral sphincter overactivity and the poor relaxing pelvic floor muscles in women with voiding dysfunction. Peng CH; Chen SF; Kuo HC Neurourol Urodyn; 2017 Nov; 36(8):2169-2175. PubMed ID: 28346720 [TBL] [Abstract][Full Text] [Related]
4. Predictive Factors for the Successful Outcome of Urethral Sphincter Injections of Botulinum Toxin A for Non-Neurogenic Dysfunctional Voiding in Women. Yang CC; Jiang YH; Kuo HC Toxins (Basel); 2024 Sep; 16(9):. PubMed ID: 39330844 [TBL] [Abstract][Full Text] [Related]
5. Female bladder neck dysfunction-A video-urodynamic diagnosis among women with voiding dysfunction. Ong HL; Lee CL; Kuo HC Low Urin Tract Symptoms; 2020 Sep; 12(3):278-284. PubMed ID: 32510853 [TBL] [Abstract][Full Text] [Related]
6. Obstructive patterns in videourodynamic studies predict responses of female dysfunctional voiding treated with or without urethral botulinum toxin injection: a long-term follow-up study. Chow PM; Hsiao SM; Kuo HC Int Urogynecol J; 2020 Dec; 31(12):2557-2564. PubMed ID: 32556406 [TBL] [Abstract][Full Text] [Related]
7. Videourodynamic characteristics of interstitial cystitis/bladder pain syndrome-The role of bladder outlet dysfunction in the pathophysiology. Kuo YC; Kuo HC Neurourol Urodyn; 2018 Aug; 37(6):1971-1977. PubMed ID: 29504632 [TBL] [Abstract][Full Text] [Related]
8. Urethral Sphincter Botulinum Toxin A Injection for Non-Spinal Cord Injured Patients with Voiding Dysfunction without Anatomical Obstructions: Which Patients Benefit Most? Chen SF; Kuo HC Toxins (Basel); 2023 Jan; 15(2):. PubMed ID: 36828402 [TBL] [Abstract][Full Text] [Related]
9. Video-urodynamic characteristics of non-neurogenic, idiopathic underactive bladder in men - A comparison of men with normal tracing and bladder outlet obstruction. Jiang YH; Kuo HC PLoS One; 2017; 12(4):e0174593. PubMed ID: 28376105 [TBL] [Abstract][Full Text] [Related]
10. Performance of urinary biomarkers in differentiating dysfunctional voiding in women with overactive bladder syndrome: a prospective pilot study. Chow PM; Kuo HC Int Urol Nephrol; 2022 Oct; 54(10):2497-2502. PubMed ID: 35857158 [TBL] [Abstract][Full Text] [Related]
11. Treatment outcomes of detrusor underactivity in women based on clinical and videourodynamic characteristics. Chen SF; Jhang JF; Jiang YH; Kuo HC Int Urol Nephrol; 2022 Jun; 54(6):1215-1223. PubMed ID: 35294677 [TBL] [Abstract][Full Text] [Related]
12. Impact of posterior urethral diameter/external urethral sphincter diameter as a new tool to predict detrusor pressure in the voiding phase. Kon M; Mitsui T; Kitta T; Moriya K; Shinohara N; Takeda M; Nonomura K Int Urol Nephrol; 2018 Feb; 50(2):211-215. PubMed ID: 29243203 [TBL] [Abstract][Full Text] [Related]
13. Voiding Dysfunction Due to Urethral Sphincter Dysfunction Might Be an Early Neurological Presentation of Central Nervous System Disorders in Aged Patients. Ho GR; Wei CW; Kuo HC J Pers Med; 2023 Apr; 13(4):. PubMed ID: 37109078 [TBL] [Abstract][Full Text] [Related]
14. Therapeutic Effects of Botulinum Toxin A, via Urethral Sphincter Injection on Voiding Dysfunction Due to Different Bladder and Urethral Sphincter Dysfunctions. Lee YK; Kuo HC Toxins (Basel); 2019 Aug; 11(9):. PubMed ID: 31450851 [TBL] [Abstract][Full Text] [Related]
15. Videourodynamic factors predictive of successful onabotulinumtoxinA urethral sphincter injection for neurogenic or non-neurogenic detrusor underactivity. Jiang YH; Jhang JF; Chen SF; Kuo HC Low Urin Tract Symptoms; 2019 Jan; 11(1):66-71. PubMed ID: 29024564 [TBL] [Abstract][Full Text] [Related]
16. Can urodynamic diagnosis of dysfunctional voiding/external sphincter nonrelaxation be made on two-channel pressure-flow study without video-urodynamics, electromyography, or urethral pressure profilometry? Plateau detrusor pattern in perspective. Agarwal MM; Sharma S; Jain S; Prasad D; Bhaskar V; Gupta S; Kapoor R; Kapoor R Neurourol Urodyn; 2022 Apr; 41(4):935-944. PubMed ID: 35233829 [TBL] [Abstract][Full Text] [Related]
17. Transurethral incision of congenital obstructive lesions in the posterior urethra in boys and its effect on urinary incontinence and urodynamic study. Nakamura S; Kawai S; Kubo T; Kihara T; Mori K; Nakai H BJU Int; 2011 Apr; 107(8):1304-11. PubMed ID: 20804485 [TBL] [Abstract][Full Text] [Related]
18. Therapeutic efficacy of biofeedback pelvic floor muscle exercise in women with dysfunctional voiding. Chiang CH; Jiang YH; Kuo HC Sci Rep; 2021 Jul; 11(1):13757. PubMed ID: 34215820 [TBL] [Abstract][Full Text] [Related]
19. Videourodynamic characteristics and lower urinary tract symptoms of female bladder outlet obstruction. Kuo HC Urology; 2005 Nov; 66(5):1005-9. PubMed ID: 16286113 [TBL] [Abstract][Full Text] [Related]
20. Therapeutic effect of urethral sphincter onabotulinumtoxinA injection for urethral sphincter hyperactivity. Jiang YH; Chen SF; Jhang JF; Kuo HC Neurourol Urodyn; 2018 Nov; 37(8):2651-2657. PubMed ID: 29797345 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]